No Data
No Data
Express News | D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target
MediciNova: Supplementary explanation of financial results for the fiscal year ending 2024/12
MediciNova: Summary of Financial Results for the Fiscal Year Ending 2024/12 [American GAAP] (Consolidated)
MediciNova: Notice regarding the difference between consolidated earnings and the results for the previous fiscal year
MediciNova | 10-K: FY2024 Annual Report
Earnings Preview: MediciNova to Report Financial Results Post-market on February 14